Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Updated follow-up of patients treated with bortezomib for relapsed multiple myeloma

Nature Clinical Practice Oncology volume 5, pages 304–305 (2008)Cite this article

Richardson PG et al. (2007) Extended follow-up of a phase 3 trial in relapsed multiple myeloma: final time-to-event results of the APEX trial. Blood 110: 3557–3560

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Russo A et al. (2007) Targeting apoptosis in solid tumors: the role of bortezomib from preclinical to clinical evidence. Expert Opin Ther Targets 11: 1571–1586

    Article  CAS  Google Scholar 

  2. Richardson PG et al. (2003) A phase 2 study of bortezomib in relapsed, refractory myeloma. N Engl J Med 348: 2609–2617

    Article  CAS  Google Scholar 

  3. Richardson PG et al. (2005) Bortezomib or high-dose dexamethasone for relapsed multiple myeloma. N Engl J Med 352: 2487–2498

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Mandy Aujla, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. B Vincenzi is a Medical Oncologist in the Medical Oncology Department, D Santini is Assistant Professor in Immunology and Medical Oncology, and G Tonini is Associate Professor of Medical Oncology, at University Campus Bio-Medico, Rome, Italy.,

    Daniele Santini, Bruno Vincenzi & Giuseppe Tonini

Authors
  1. Daniele Santini
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bruno Vincenzi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Giuseppe Tonini
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Daniele Santini.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Santini, D., Vincenzi, B. & Tonini, G. Updated follow-up of patients treated with bortezomib for relapsed multiple myeloma. Nat Rev Clin Oncol 5, 304–305 (2008). https://doi.org/10.1038/ncponc1127

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncponc1127

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing